Related Experiment Video
Updated: May 7, 2026
11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.0K
Disseminated Cryptococcal Infection in Treatment-Naive Patients With Chronic Lymphocytic Leukemia (CLL).
Kakha Gujabidze1, Subaha Akram Hussain1, Stephanie Balint2
1Internal Medicine, Saint Mary's Hospital, Waterbury, USA.
Cureus
|May 27, 2024
Summary
This case report details a rare disseminated cryptococcal infection in an elderly male with untreated chronic lymphocytic leukemia (CLL). Early antifungal treatment is vital for managing this opportunistic fungal infection in immunocompromised patients.
Area of Science:
- Infectious Diseases
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a hematologic malignancy associated with immune dysfunction.
- Patients with CLL are susceptible to opportunistic infections, including fungal infections.
- Disseminated fungal infections can be life-threatening in immunocompromised individuals.
Observation:
- An elderly male with untreated chronic lymphocytic leukemia (CLL) presented with respiratory symptoms.
- Blood cultures revealed the presence of *Cryptococcus neoformans*.
- Central nervous system involvement was notably absent in this patient.
Findings:
- The patient experienced a rare disseminated cryptococcal infection.
- Prompt initiation of antifungal therapy was critical for management.
- The infection occurred despite the absence of prior CLL treatment.
Implications:
- This case highlights the importance of considering fungal infections in CLL patients.
- Immunological vulnerabilities in CLL increase the risk of opportunistic infections.
- Early diagnosis and management are essential for improving outcomes in CLL patients with fungal infections.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...